Upchurch K S, Leyva A, Arnold W J, Holmes E W, Kelley W N
Proc Natl Acad Sci U S A. 1975 Oct;72(10):4142-6. doi: 10.1073/pnas.72.10.4142.
In the present study hemolysates from fourteen patients with a genetically determined deficiency of hypoxanthine phosphoribosyltransferase (EC 2.4.2.8; IMP:pyrophosphate phosphoribosyltransferase) activity were examined immunologically for the presence of material that crossreacts with the normal enzyme. A quantitative assay for crossreacting material in enzyme-deficient hemolysates was based on the inhibition of the immunoprecipitation of the normal enzyme. As little as 3% of normal crossreacting material could be detected. One patient in this series was found to have a normal amount of crossreacting material, whereas the remainder had no detectable crossreacting protein. The lack of detectable crossreacting material in these patients raises the possibility that a defect in synthesis or degradation of enzyme protein may be present in many patients deficient in hypoxanthine phosphoribosyltransferase.
在本研究中,对14例因基因决定而次黄嘌呤磷酸核糖基转移酶(EC 2.4.2.8;IMP:焦磷酸磷酸核糖基转移酶)活性缺乏的患者的溶血产物进行了免疫学检查,以检测是否存在与正常酶发生交叉反应的物质。基于对正常酶免疫沉淀的抑制作用,对酶缺陷溶血产物中的交叉反应物质进行了定量测定。低至3%的正常交叉反应物质都能被检测到。该系列中有1例患者被发现具有正常量的交叉反应物质,而其余患者均未检测到交叉反应蛋白。这些患者中缺乏可检测到的交叉反应物质,这增加了一种可能性,即许多次黄嘌呤磷酸核糖基转移酶缺乏的患者可能存在酶蛋白合成或降解缺陷。